Pete Foley Joins CMTA Board of Directors
Glenolden, PA, June 21, 2021—The Charcot-Marie-Tooth Association (CMTA), the national patient advocacy organization leading CMT research, today announced the appointment of Pete Foley to its Board of Directors. Originally from…
CMTA Announces New Center of Excellence in Kentucky
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is excited…
Walk 4 CMT with CMTA Youth Council Member Riley Williams
…CMT Facebook page www.facebook.com/Walk4CMT. 2020 Walk 4 CMT Locations California Los Angeles Palo Alto San Diego Colorado Denver District of Columbia Washington DC Florida Miami Parkland Tampa Georgia Atlanta Illinois…
CMT2C: Share Your Story
…future of CMT2C clinical research. CMTA’s Commitment to Patient-Centered Research CMTA remains committed to supporting patient-centered research, and along with our CMTA-STAR Alliance Partner Actio Biosciences, we are excited to…
CMTA-STAR Advisory Board Member Dr. D’Antonio Publishes in Brain, Identifies Potential Therapeutic Target for CMT1B
…therapeutic target not only for CMT1B but also for other demyelinating forms of CMT, including CMT1A and CMT1E. In CMT1B, mutations in the MPZ gene can cause Schwann cells, which…
The Differences Between Charcot-Marie-Tooth Disease and Muscular Dystrophy (MD): An Overview
…No, CMT is not a form of MD. Although CMT shares many symptoms with the many forms of MD, CMT is a disease of the peripheral nerves and MD is…
Voice_of_the_Patient_Report_8-19-2019
CMT-and-Genetic-Testing-Why-Is-It-Important
The 2020 Winter CMTA Report
…see in the world of CMT. Be the Change: A Message from CEO Amy Gray Swimming Uphill with Jamal Hill CMTA Funds Cutting-Edge Gene Editing Studies for Type 2 CMT…
CMTA Appoints Science and Technology Veteran, Patricia Verduin, PhD, to the Board of Directors
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments and a cure to patients, is pleased to announce the appointment of a…